HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qi Zeng Selected Research

Human papillomavirus type 16 oncogene protein E7

7/2011Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qi Zeng Research Topics

Disease

69Neoplasms (Cancer)
01/2022 - 10/2004
25Neoplasm Metastasis (Metastasis)
01/2022 - 10/2004
8Inflammation (Inflammations)
10/2022 - 04/2012
8Nasopharyngeal Carcinoma
01/2022 - 02/2010
7Carcinogenesis
12/2021 - 04/2008
6Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 05/2008
6Breast Neoplasms (Breast Cancer)
01/2021 - 09/2004
6Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 10/2004
5Epilepsy (Aura)
05/2022 - 07/2019
5Seizures (Absence Seizure)
05/2022 - 07/2019
5Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2022 - 05/2009
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2020 - 06/2014
4Prostatic Neoplasms (Prostate Cancer)
06/2022 - 08/2019
4Infections
04/2022 - 04/2015
4Hypoxia (Hypoxemia)
12/2021 - 09/2015
3AIDS-Related Complex (ARC)
03/2022 - 01/2019
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2022
3COVID-19
10/2020 - 01/2020
3Colonic Neoplasms (Colon Cancer)
01/2013 - 05/2008
2Cognitive Dysfunction
01/2022 - 01/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2011
2Nervous System Diseases (Neurological Disorders)
01/2022 - 01/2021
2Genomic Instability
12/2021 - 01/2018
2Lung Injury
07/2021 - 01/2021
2Pneumonia (Pneumonitis)
07/2021 - 01/2020
2Neuroblastoma
06/2021 - 09/2020
2Urinary Bladder Neoplasms (Bladder Cancer)
12/2020 - 11/2020
2Virus Diseases (Viral Diseases)
01/2020 - 04/2015
2Wounds and Injuries (Trauma)
01/2020 - 01/2016
2Oral Lichen Planus
02/2018 - 10/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 05/2016
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2017 - 04/2016
2Carcinoma (Carcinomatosis)
09/2015 - 02/2005
2Melanoma (Melanoma, Malignant)
02/2012 - 04/2011
1Major Depressive Disorder (Major Depressive Disorders)
10/2022
1Bacterial Infections (Bacterial Infection)
10/2022
1Reperfusion Injury
06/2022
1Ischemia
06/2022

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2004
21Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2019 - 10/2004
12Pharmaceutical PreparationsIBA
10/2022 - 10/2004
11Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2005
9Messenger RNA (mRNA)IBA
01/2022 - 03/2005
7Oncogene Proteins (Oncogene Protein)IBA
11/2021 - 05/2008
7AntigensIBA
01/2021 - 05/2009
6Biological ProductsIBA
06/2022 - 07/2018
5AntibodiesIBA
01/2016 - 05/2008
4MicroRNAs (MicroRNA)IBA
10/2022 - 11/2020
4CytokinesIBA
10/2022 - 07/2011
4Peptides (Polypeptides)IBA
10/2022 - 07/2011
4Silicon Dioxide (Silica)FDA LinkGeneric
10/2022 - 01/2018
4Valproic Acid (Depakote)FDA LinkGeneric
05/2022 - 01/2022
4Carboplatin (JM8)FDA LinkGeneric
03/2022 - 02/2010
4LigandsIBA
01/2022 - 04/2015
4Indicators and Reagents (Reagents)IBA
01/2021 - 05/2008
4Protein Tyrosine PhosphatasesIBA
01/2015 - 10/2004
3ChemokinesIBA
06/2022 - 08/2021
3Levetiracetam (Keppra)FDA LinkGeneric
05/2022 - 01/2022
3Cisplatin (Platino)FDA LinkGeneric
03/2022 - 05/2009
3LipopolysaccharidesIBA
01/2022 - 02/2018
3Therapeutic UsesIBA
01/2021 - 02/2012
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 05/2009
2Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 04/2022
2Long Noncoding RNAIBA
06/2022 - 11/2020
2ProdrugsIBA
01/2022 - 01/2018
2Peptide Hydrolases (Proteases)FDA Link
01/2022 - 01/2020
2LuciferasesIBA
01/2022 - 12/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 10/2018
2Circular RNAIBA
08/2021 - 12/2020
2Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 09/2004
2Nucleic AcidsIBA
10/2020 - 01/2020
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 09/2019
2Small Interfering RNA (siRNA)IBA
01/2019 - 06/2012
2Contrast MediaIBA
01/2019 - 09/2015
2DNA VaccinesIBA
01/2017 - 02/2012
2Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 02/2010
2Docetaxel (Taxotere)FDA Link
01/2016 - 02/2010
2PlatinumIBA
01/2016 - 02/2010
2Cancer VaccinesIBA
04/2015 - 09/2011
2InterferonsIBA
04/2015 - 10/2004
2Neoplasm Antigens (Tumor Antigens)IBA
04/2015 - 01/2014
2Paclitaxel (Taxol)FDA LinkGeneric
07/2014 - 04/2014
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2013 - 10/2004
2Tyrosine (L-Tyrosine)FDA Link
09/2012 - 05/2011
2AgarIBA
06/2012 - 04/2008
2Monoclonal AntibodiesIBA
05/2008 - 03/2005
1ConalbuminIBA
10/2022

Therapy/Procedure

27Therapeutics
05/2022 - 05/2008
18Drug Therapy (Chemotherapy)
03/2022 - 05/2009
16Radiotherapy
03/2022 - 03/2008
7Immunotherapy
11/2021 - 07/2011
4Chemoradiotherapy
03/2022 - 02/2010
3Precision Medicine
05/2022 - 01/2021
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2022 - 03/2022
2Electrodes (Electrode)
02/2022 - 01/2016
2Photochemotherapy (Photodynamic Therapy)
05/2019 - 01/2019
2Thoracotomy
01/2019 - 12/2018
2Induction Chemotherapy
01/2016 - 09/2015
2Radiofrequency Ablation
09/2015 - 03/2015